<VariationArchive VariationID="1691479" VariationName="NM_000212.3(ITGB3):c.2031_2041del (p.Asp677fs)" VariationType="Deletion" Accession="VCV001691479" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2022-06-18" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1683958" VariationID="1691479">
      <GeneList>
        <Gene Symbol="ITGB3" FullName="integrin subunit beta 3" GeneID="3690" HGNC_ID="HGNC:6156" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="47253827" stop="47313743" display_start="47253827" display_stop="47313743" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="45331207" stop="45390076" display_start="45331207" display_stop="45390076" Strand="+" />
          </Location>
          <OMIM>173470</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ITGB3">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ITGB3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000212.3(ITGB3):c.2031_2041del (p.Asp677fs)</Name>
      <CanonicalSPDI>NC_000017.11:47302736:TGCAGTGAATT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="47302737" stop="47302747" display_start="47302737" display_stop="47302747" variantLength="11" positionVCF="47302736" referenceAlleleVCF="ATGCAGTGAATT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="45380103" stop="45380113" display_start="45380103" display_stop="45380113" variantLength="11" positionVCF="45380102" referenceAlleleVCF="ATGCAGTGAATT" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>NM_000212.3:c.2031_2041del</Name>
      </OtherNameList>
      <ProteinChange>D677fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.45380103_45380113del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.45380103_45380113del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.47302737_47302747del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.47302737_47302747del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008332.2" sequenceAccession="NG_008332" sequenceVersion="2" change="g.53896_53906del">
            <Expression>NG_008332.2:g.53896_53906del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000212.3" sequenceAccession="NM_000212" sequenceVersion="3" change="c.2031_2041del" MANESelect="true">
            <Expression>NM_000212.3:c.2031_2041del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000203.2" sequenceAccession="NP_000203" sequenceVersion="2" change="p.Asp677fs">
            <Expression>NP_000203.2:p.Asp677fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_481" sequenceAccession="LRG_481">
            <Expression>LRG_481:g.53896_53906del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="173470.0014" DB="OMIM" />
        <XRef Type="rs" ID="2143138089" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000212.3(ITGB3):c.2031_2041del (p.Asp677fs) AND Glanzmann thrombasthenia" Accession="RCV002254814" Version="2">
        <ClassifiedConditionList TraitSetID="734">
          <ClassifiedCondition DB="MedGen" ID="C0040015">Glanzmann thrombasthenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-04-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000212.3(ITGB3):c.2031_2041del (p.Asp677fs) AND Glanzmann thrombasthenia 2" Accession="RCV002286590" Version="1">
        <ClassifiedConditionList TraitSetID="66021">
          <ClassifiedCondition DB="MedGen" ID="C5543273">Glanzmann thrombasthenia 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1991-04-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000212.3(ITGB3):c.2031_2041del (p.Asp677fs) AND not provided" Accession="RCV003560899" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-07" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2022-06-18" MostRecentSubmission="2024-02-14">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2014236</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21917754</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/7ee8b02a-62e1-4a04-8a76-56ad88a08791</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="66021" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="56009" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glanzmann thrombasthenia 2</ElementValue>
                <XRef ID="MONDO:0031009" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLEEDING DISORDER, PLATELET-TYPE, 23</ElementValue>
                <XRef Type="MIM" ID="619267" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GT2</ElementValue>
                <XRef Type="MIM" ID="619267" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BDPLT23</ElementValue>
                <XRef Type="MIM" ID="619267" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16439" />
                <XRef ID="16439" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C5543273" DB="MedGen" />
              <XRef ID="MONDO:0031009" DB="MONDO" />
              <XRef Type="MIM" ID="619267" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="734" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3893" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia of Glanzmann and Naegeli</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLEEDING DISORDER, PLATELET-TYPE, 2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glanzmann thrombasthenia</ElementValue>
                <XRef ID="MONDO:0100326" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann thrombasthenia type A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diacyclothrombopathia 2B 3A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann's thrombasthenia</ElementValue>
                <XRef ID="Thrombasthenia+of+Glanzmann+and+Naegeli/7074" DB="Genetic Alliance" />
                <XRef ID="32942005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BDPLT2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2478" />
                <XRef ID="2478" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="849" DB="Orphanet" />
              <XRef ID="C0040015" DB="MedGen" />
              <XRef ID="MONDO:0100326" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS273800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="4949138" SubmissionDate="2022-06-13" DateLastUpdated="2022-06-18" DateCreated="2022-06-18">
        <ClinVarSubmissionID localKey="7ee8b02a-62e1-4a04-8a76-56ad88a08791" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002525907" DateUpdated="2022-06-18" DateCreated="2022-06-18" Type="SCV" Version="1" SubmitterName="ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen" OrgID="507662" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-07">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/7ee8b02a-62e1-4a04-8a76-56ad88a08791</URL>
          </Citation>
          <Comment>NM_000212.3(ITGB3):c.2031_2041del in exon 13/15 is a frameshift variant creating p.(Asp677Glufs*4), where it is predicted to cause a premature stop codon and lead to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This is thought to be a founder variant in the Iraqi-Jewish population and has been identified in at least 12 patients from 9 kindreds (PMID: 2014236). At least two patients (Patients 2 and 4 in PMID: 30078718) with this variant displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia (PP4_moderate). Additionally, alphaIIbbeta3 surface expression was absent as measured by flow cytometry. Patient 2 is homozygous for the variant (PM3_supporting). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PVS1, PP4_moderate, PM2_supporting, PM3_supporting. (VCEP specifications version 2; date of approval 01/18/2022)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen Platelet ACMG Specifications v2-1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/mac6zhy2/clingen_platelet_acmg_specifications_v2-1.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000212.3:c.2031_2041del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.47302737_47302747del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100326" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11603908</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="34785" SubmissionDate="2010-12-30" DateLastUpdated="2022-07-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="173470.0014_GLANZMANN THROMBASTHENIA 2" title="ITGB3, 11-BP DEL, EX12_GLANZMANN THROMBASTHENIA 2" />
        <ClinVarAccession Accession="SCV000034785" DateUpdated="2022-07-08" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1991-04-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 6 unrelated Iraqi-Jewish patients with Glanzmann thrombasthenia (GT2; 619267), Newman et al. (1991) identified an 11-bp deletion in exon 12 of the GP3A gene.</Attribute>
              <Citation>
                <ID Source="PubMed">2014236</ID>
              </Citation>
              <XRef DB="OMIM" ID="619267" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGB3" />
          </GeneList>
          <Name>ITGB3, 11-BP DEL, EX12</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">11-BP DEL, EX12</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="173470.0014" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLANZMANN THROMBASTHENIA 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7983090" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4943628|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004298268" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21917754</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2014236</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asp677Glufs*4) in the ITGB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ITGB3 are known to be pathogenic (PMID: 21917754). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Glanzmann's thrombasthenia (PMID: 2014236). This variant is also known as 11-bp deletion starting at base 2051. ClinVar contains an entry for this variant (Variation ID: 1691479). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.45380103_45380113del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="34785" TraitType="Disease" MappingType="Name" MappingValue="GLANZMANN THROMBASTHENIA 2" MappingRef="Preferred">
        <MedGen CUI="C5543273" Name="Glanzmann thrombasthenia 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7983090" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4949138" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100326" MappingRef="MONDO">
        <MedGen CUI="C0040015" Name="Glanzmann thrombasthenia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

